bioRxiv Science⌕ Search

bioRxiv · 10.64898/2025.12.12.693865

A systems genetics approach to uncover mitochondrial drivers of heart failure reveals mitochondria-nuclear cross talk in genetically diverse mouse strains

Abstract

The contribution of mitochondrial genetics to heart failure is thought to be reciprocal. Its complex traits are influenced by genetic and environmental factors. Genetically diverse mouse strains form a vital repository to uncover the interaction between the mitochondrial and nuclear genomes underlying heart failure due to their traceable genetic origins, maternal lineages and controlled genetic variation. Using systems genetics, we studied this cross-talk in the Collaborative Cross (CC) mice challenged with heart failure (HF). We used 63 strains of CC-mice that grouped into 8 mitochondrial haplotypes and subjected them to HF using isoproterenol (Iso), a beta-adrenergic stimulant that mimics progressive stress induced HF in humans. The Alzet osmotic pumps delivered a consistent dose of the drug for 21 days following which the mice were euthanized for organ collection. A group of mice with saline loaded pumps acted as control (Ctrl). Baseline and end of study echocardiography were recorded for these mice. Bulk RNA sequencing was carried out on the left ventricles and data analyzed on R-studio. The CC-strains showed differences across the haplotypes for organ weights and heart function. Noticeable treatment specific gene expression differences were observed for 34 nuclear encoded genes from MitoCarta3.0 unlike mt-DNA encoded genes that were insignificant after correcting for sex and haplotypes. These genes were associated with multiple metabolic pathways in the cell. Trait-GWAS associations with markers from the mitochondrial genome were observed only for mice from Iso group with cell surface area (p = 6.19e-06) and change in ejection fraction (p = 9.22e-05) as top hits under FWER threshold of 0.01. Cyfip2 was the top candidate gene (p = 2.66e-07) among the 831 hits (47-MitoCarta & 784 other nuclear) based on our trans-eQTL analysis. The eQTL genes influenced critical pathways of OXPHOS, myogenesis, apoptosis etc. Our approach uncovered 24 gene candidates associated with mt-DNA and HF that overlapped with our previous mi-eQTL reports. CC-mice revealed ancestry dependent effects underlying HF for studying mito-nuclear interactions. Despite establishing differences, modeling these interaction needs development of complex cybrid systems to evaluate the bidirectional impact on HF. Author SummaryThe Collaborative Cross (CC) mouse is a genetically diverse population that has been used to study complex diseases. Recently, our group has comprehensively characterized the heart from 63 strains of the CC and reported genetic associations with heart failure (HF). Traditionally, genetic abnormalities underlying a disease are related to the nuclear genome but there exists an alternate genome within the cells, the mitochondrial DNA (mt-DNA), whose contribution is understudied. The mt-DNA of CC mice is maternally derived from the 8 founder strains, and our sequencing data holds this information, allowing us the ability to use them to study the contribution of mitochondrial ancestry (haplotypes) to HF. We found haplotype differences in terms of cardiac function and gene expression (both nuclear and mitochondrial) that were associated with HF. It revealed stress induced changes in the heart (trait and gene expression) linked with regions in the mt-DNA that encode genes involved in oxidative phosphorylation and metabolism. We uncovered 24 high-confidence nuclear gene candidates that agreed with our previous analyses and were associated with regions on the mt-DNA. These findings open up new opportunities to study the CC and advance the understanding of Mito-nuclear interactions in HF pathophysiology.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ravindran, S., Kimball, T. H., Gural, B., Lahue, C., Rau, C. D.. 2025-12-15. A systems genetics approach to uncover mitochondrial drivers of heart failure reveals mitochondria-nuclear cross talk in genetically diverse mouse strains. https://doi.org/10.64898/2025.12.12.693865

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Large language model-based bibliometric evaluation of population descriptors in human genetics

As the use of population descriptors such as race, ethnicity, and ancestry have become increasingly common in modern genetics research, there have been growing calls to critically examine their use. Most notably, in 2023, the National Academies of Science, Engineering, and Medicine (NASEM) published a report titled Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field, which included eight specific and actionable recommendations for researchers to implement the ethical and accurate use of population descriptors in genetic research. Here, we use the 2023 NASEM report as a benchmark to analyze the use of population descriptors in genome-wide association studies (GWAS). We develop a general toolkit for large language model-based bibliometrics, operationalize the report's recommendations into an evaluation framework, and apply this framework to evaluate all 4,007 papers from the GWAS Catalog published between 2007 and 2025 with full text available on PubMedCentral. We find significant improvements in adherence to NASEM report recommendations over time. However, most improvements predate the publication of the NASEM report itself, suggesting the report functioned primarily as a synthesis of existing best practices rather than a catalyst for change. We conclude by highlighting opportunities for growth in the field of human genetics.

genetics↗

Mitigating biases of rescaling in forward-in-time population genetic simulations

Forward-in-time population genetic simulations are widely used in evolutionary analyses, but simulating large populations and long genomic regions remains computationally demanding. To reduce this cost, parameter rescaling is widely employed, in which the original evolutionary process is approximated by one with a smaller population size and fewer generations. Recently, several studies using the SLiM simulator have raised concerns about the accuracy of this rescaling approach. In this study, we show that many of the biases reported in these studies can be mitigated by using a different simulation algorithm. These results reveal that the accuracy of parameter rescaling depends on how well the simulation algorithm preserves diffusion-limit properties under rescaling.

genetics↗

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗